Genpact
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genpact and other ETFs, options, and stocks.About G
Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).
G Key Statistics
Stock Snapshot
As of today, Genpact(G) shares are valued at $44.49. The company's market cap stands at 7.75B, with a P/E ratio of 14.33 and a dividend yield of 1.5%.
On 2025-11-08, Genpact(G) stock moved within a range of $41.55 to $45.29. With shares now at $44.49, the stock is trading +7.1% above its intraday low and -1.8% below the session's peak.
Trading activity shows a volume of 7.04M, compared to an average daily volume of 2.77M.
The stock's 52-week range extends from a low of $37.49 to a high of $56.76.
The stock's 52-week range extends from a low of $37.49 to a high of $56.76.
G News
Genpact ((G)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can hel...
The company is reaping the benefits of being a tech-forward solutions provider. Business process management company Genpact Limited (G +15.89%) managed to post...
Genpact (G) is up 17.2%, or $6.61 to $45.00. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI...
Analyst ratings
64%
of 14 ratingsMore G News
Genpact recently reported third quarter results for 2025, showing an increase in net revenues and earnings, and announced raised full-year earnings and revenue...
Mayank Tandon, an analyst from Needham, reiterated the Buy rating on Genpact. The associated price target remains the same with $53.00. Meet Your ETF AI Analyst...
Earnings Call Insights Genpact raises full-year revenue growth outlook to 6.4% amid accelerating advanced technology solutions momentum Nov. 06, 2025 11:26 PM E...
Bryan Bergin, an analyst from TD Cowen, reiterated the Buy rating on Genpact. The associated price target remains the same with $55.00. Meet Your ETF AI Analyst...